TrialHaematologica2016

Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients.

UK CLL ForumPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.